Differentiating biosimilarity and comparability in biotherapeutics.
about
Biosimilar biologic drugs: a new frontier in medical care.Biosimilars in rheumatology: recommendations for regulation and use in Middle Eastern countries.Biosimilar Drugs for Psoriasis: Principles, Present, and Near Future.Analytical comparability study of recombinant monoclonal antibody therapeutics.The biosimilars journey: current status and ongoing challenges
P2860
Differentiating biosimilarity and comparability in biotherapeutics.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Differentiating biosimilarity and comparability in biotherapeutics.
@en
type
label
Differentiating biosimilarity and comparability in biotherapeutics.
@en
prefLabel
Differentiating biosimilarity and comparability in biotherapeutics.
@en
P2093
P2860
P1476
Differentiating biosimilarity and comparability in biotherapeutics.
@en
P2093
Brian Fitzpatrick
Brian Hassett
Ehab Mahgoub
Ira Jacobs
Javier Coindreau
João Eurico Fonseca
Julie O'Brien
Steven Vicik
Tatsuya Atsumi
P2860
P304
P356
10.1007/S10067-016-3427-2
P577
2016-10-12T00:00:00Z